BGLAP
EstablishedBGLAP encodes osteocalcin, a bone-formation marker used to monitor osteoporosis treatment.
Osteocalcin is a protein made by bone-building cells and reflects how active bone formation is. Beyond bones, some research suggests its undercarboxylated form may even influence insulin sensitivity, an unexpected role outside the skeleton.
BGLAP encodes osteocalcin, the most abundant non-collagenous protein in bone, secreted by osteoblasts during bone formation and serving as a marker of bone turnover.
Osteocalcin levels reflect bone formation activity; elevated levels occur in high bone-turnover states like growth or Paget's disease, while low levels suggest osteoporosis or vitamin K deficiency (since osteocalcin requires vitamin K for full function).
Measured via serum immunoassay, typically alongside a bone resorption marker (like CTX) for a fuller bone-turnover picture; used to monitor antiresorptive therapy (bisphosphonates, denosumab) response in osteoporosis.
Serial osteocalcin can help confirm adequate response to osteoporosis treatment, typically alongside bone-specific alkaline phosphatase or CTX rather than as a stand-alone marker.
A standard bone formation marker, often paired with a resorption marker like CTX for bisphosphonate monitoring.
- Walk-In Lab Resource Center. (2026). Osteocalcin.
- Frontiers in Endocrinology. Osteocalcin: Beyond Bones. (2024).